Opulis
Withdrawn
desloratadine
MedicineHumanWithdrawn
The marketing authorisation for Opulis has been withdrawn at the request of the marketing authorisation holder.
10/03/2004
This medicine’s product information is available in all official EU languages.
Select 'available languages' to access the language you need.
Product information documents contain:
Opulis is indicated for the relief of symptoms associated with:
- allergic rhinitis (see section 5.1)
- urticaria (see section 5.1)